Skip to main navigation
Skip to main content
Consumer Healthcare Products Association
Taking healthcare personally.
User account menu
About CHPA
Membership
Health In Hand Foundation
Career Center
Login
Our Issues
OTC Medicines
Acetaminophen
Children's Cough and Cold Medicines
DXM (Dextromethorphan)
Monograph Reform
NSAIDs
OTC Distribution
Pediatrics Medicine
PE (Phenylephrine)
PSE (Pseudoephedrine)
RX-to-OTC Switch
Sunscreen
Take Back/Drug Disposal
Dietary Supplements
CBD and Hemp Oil
DSHEA
Immunity
New Dietary Ingredients
Probiotics
Vitamins and Minerals
OTC Medical Devices
510(K) Modifications
Other Issues
Branding
Digital Health
FSA/HSA
Good Manufacturing Practices
Health Literacy
Ingredient Safety
Labeling
NPLEx (National Precursor Log Exchange)
Packaging
PFAS
Quality
Research
Sales Tax Exemption
Supply Chain
Sustainability
Public Policy & Regulatory
Regulation
Regulation of OTC Medicines
Regulation of Dietary Supplements
Regulation of OTC Medical Devices
Submissions
FDA Annual Forecast
Current Good Manufacturing Practices
Federal Legislative Priorities
Cargo Theft
Dietary Supplements Access Act
Expanding FSA/HSA Eligibility for Oral Care Products
State & Local Government Affairs
Critical Ingredients & Chemicals
Dietary Supplements in the States
OTC Medications in the States
Sustainability Issues in the States
State Government Reports
Voluntary Codes and Guidelines
OTC Voluntary Codes and Guidelines
Industry Self-Regulation for Dietary Supplements
Events & Education
Annual Self-Care Leadership Summit
CHPA Academy
Consumer Healthcare 101
Regulatory, Scientific & Quality Conference
Regulatory & Scientific Affairs Career Achievement Award
Health In Hand Foundation Gala
Self-Care Marketing Awards
Marketing Forum
Meetings & Education Calendar
Become A Sponsor
About Consumer Healthcare
Research & Data
Research Reports
OTC Sales Statistics
OTC Medical Device Statistics
Dietary Supplement Resource Library
Multimedia
Infographics
Videos
Podcast
FAQs
Activities & Initiatives
Preventing Dextromethorphan Abuse
Preventing Illegal Meth Production
Safe Use of Acetaminophen
Tax Free OTC
The Value of OTC Medicines
News
Open Search
Keywords
Open Menu
Main navigation
Our Issues
OTC Medicines
Acetaminophen
Children's Cough and Cold Medicines
DXM (Dextromethorphan)
Monograph Reform
User Fees
NSAIDs
OTC Distribution
Pediatrics Medicine
PE (Phenylephrine)
PSE (Pseudoephedrine)
RX-to-OTC Switch
Sunscreen
Take Back/Drug Disposal
Dietary Supplements
CBD and Hemp Oil
DSHEA
Immunity
New Dietary Ingredients
Probiotics
Vitamins and Minerals
OTC Medical Devices
510(K) Modifications
Other Issues
Branding
Digital Health
FSA/HSA
Good Manufacturing Practices
Health Literacy
Ingredient Safety
Labeling
NPLEx (National Precursor Log Exchange)
Packaging
PFAS
Quality
Research
Sales Tax Exemption
Supply Chain
Sustainability
Public Policy & Regulatory
Regulation
Regulation of OTC Medicines
Child-Resistant Packaging
Switch List
Drug Distribution and National Uniformity
OTC Drug Advertising
Structured Product Labeling
Regulation of Dietary Supplements
Labeling Dietary Supplements
Marketing and Advertising Dietary Supplements
Standardized Information on Dietary Ingredients (SIDI)
Dietary Supplement Safety
Regulation of OTC Medical Devices
Submissions
FDA Annual Forecast
Effectiveness of Phenylephrine as an Oral Decongestant
Pediatric Cough/Cold Dosing
Risks Associated with Codeine-Containing Cough Medicine
Pediatric Acetaminophen Dosing
Risks Associated with Propylhexedrine Abuse and Misuse
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Oligohydramnios
Oral Healthcare in Infants and Children - Benzocaine and/or Phenol Preparations
Proposed Safety Administrative Order for Serious Skin reactions Associated with Acetaminophen
Anticaries Test Methods
Risks Associated with use of Ipecac Syrp as OTC Poison Treatment
Current Good Manufacturing Practices
Federal Legislative Priorities
Cargo Theft
Dietary Supplements Access Act
Expanding FSA/HSA Eligibility for Oral Care Products
State & Local Government Affairs
Critical Ingredients & Chemicals
Acetaminophen
Color Additives
Dextromethorphan
Diphenhydramine
Loperamide
Pseudoephedrine
Volatile Organic Compounds
Dietary Supplements in the States
OTC Medications in the States
Animal Testing
Dispensing Authority
Ingredient Disclosure
Emergency Scheduling of Ingredients
Insurance Coverage
Labeling OTC Medications
Sales Tax
Supply Chain
Vending Machine Sales
Sustainability Issues in the States
Batteries in OTC Devices
Chemical Restrictions in Children’s Products
Drug Take-Back
Green Chemistry
Microplastics
PFAS
Packaging
Proposition 65
Sunscreen
State Government Reports
Voluntary Codes and Guidelines
OTC Voluntary Codes and Guidelines
Industry Self-Regulation for Dietary Supplements
Events & Education
Annual Self-Care Leadership Summit
CHPA Academy
Consumer Healthcare 101
Regulatory, Scientific & Quality Conference
Regulatory & Scientific Affairs Career Achievement Award
Health In Hand Foundation Gala
Self-Care Marketing Awards
Marketing Forum
Meetings & Education Calendar
Become A Sponsor
About Consumer Healthcare
Research & Data
Research Reports
OTC Sales Statistics
OTC Medical Device Statistics
Dietary Supplement Resource Library
Multimedia
Infographics
Videos
Podcast
FAQs
Activities & Initiatives
Preventing Dextromethorphan Abuse
Preventing Illegal Meth Production
Safe Use of Acetaminophen
Tax Free OTC
The Value of OTC Medicines
News
User account menu
About CHPA
Our Team
Our Members
Our Committees
Board of Directors
Executive Committee
Strategic Priorities
Diversity, Equity, & Inclusion
Women's Leadership Forum
Awards
Careers at CHPA
Contact Us
Membership
Health In Hand Foundation
Career Center
Login
LinkedIn
YouTube
Twitter
Facebook
Breadcrumb
Home
About CHPA
Andrew Stewart
Andrew Stewart
Head of Real-World Evidence and Behavioral Science, Sanofi Consumer Healthcare
